Current Pharmaceutical Design

Prof. Eleonore Fröhlich obtained her Medical degree and her Diploma in Biochemistry from the Universities Tübingen and Heidelberg (Germany) and specialized in Anatomy, Histology, and Embryology. Since 2007 she is Director of the Core Facility Imaging at the Medical University of Graz (Austria). She is also associate professor at the Institute of Anatomy (Tübingen) and Key Researcher at the Research Center Pharmaceutical Engineering (Graz). Her research activities focus on in vitro toxicity testing and biological aspects of drug delivery to the lungs. Her scientific achievements include publication of 150+ articles (H-index: 39), acting as reviewer for 150+ scientific international journals and >20 grant agencies and Editorial functions in seven peer-reviewed journals.

Concettina La Motta graduated cum laude in the long-term degree course of Pharmaceutical Chemistry and Technology, in 1992, at the Faculty of Pharmacy of the University of Pisa, Italy. From 1992 to 1996 she worked at the pharmaceutical company Farmigea S.p.A, Research and Development Division, than she obtained her PhD in Medicinal Chemistry, in 1999. Assistant Professor, from 2000 to 2011, she now works as associate professor of medicinal chemistry at the Department of Pharmacy of the University of Pisa, Italy. She is the author of more than 140 publications in the fields of medicinal chemistry, including research articles in leading international journals, national and international patents, chapters in books, published by major presses, and a number of oral and poster communications at national and international congresses. On the basis of her research, many students have been awarded their master and Ph.D degrees in medicinal chemistry. She serves as reviewer of papers for publishers like the American Chemical Society Publication, Elsevier Ltd, Wiley Interscience, and RSC Journals, as well as reviewer of research proposals for agencies like the Italian and European Ministries of Education and Research.

Prof. Atta-ur-Rahman, Ph.D. in organic chemistry from Kings College, University of Cambridge (1968), has 1235 international publications in several fields of organic chemistry including, 349 books published largely by major U.S. and European presses. He was elected as Fellow of Royal Society (London) (2006) and won the prestigious UNESCO Science Prize (1999). Prof. Atta-ur-Rahman was conferred honorary D.Sc. degrees by many leading world universities including the University of Cambridge and appointed an Honorary Life Fellow of Kings College, University of Cambridge. The Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007). He is Professor Emeritus at the University of Karachi, Pakistan. Prof. Atta-ur-Rahman was appointed Academician (Foreign Member) of the Chinese Academy of Sciences (2015). He won the “Friendship Award of China” (2014) and was conferred the highest scientific award of China, the International Science & Technology Cooperation Award, by President Xi Jinping (2020). He was bestowed with the International Scientific Corporation Award (2014) and the “Einstein Professorship” by the Chinese Academy of Sciences (CAS) (2013). He was also elected as Foreign Member of the Korean Academy of Science and Technology. Research Institutes have been established in his name in China, Malaysia and Pakistan.

Abba J. Kastin was born in Ohio and educated at Harvard College and Harvard Medical School. After starting his work on neuropeptides as a Clinical Associate at NIH, he went to Louisiana where he now holds an endowed chair at the Pennington Biomedical Research Center. In recognition of the concepts he introduced into the field of biologically active peptides, Dr. Kastin has been made an honorary member of 9 foreign medical societies, has received 2 honorary professorships and 3 honorary doctorates (the last one from Uppsala University), and has won several national and international awards. Author of more than 900 papers cited more than 34,500 times (H index 87), he has been listed among the 100 researchers most cited in the scientific literature. He is president of The International Neuropeptide Society/Society for Biologically Active Peptides and was founding Editor-in-Chief of the international journal Peptides for 35 years.

Andrew V. Schally, Ph.D., M.D.h.c., received his training in England, Canada, Sweden, and USA. In the years 1954-1977 he worked in the field of neuroendocrinology. Dr. Schally’s group isolated and elucidated the structure of hypothalamic LHRH. Dr. Schally was awarded the Nobel Prize in Medicine in 1977 for his work on hypothalamic peptides. Dr. Schally switched then to cancer research. He is a world leader in research on hormone-related cancers and treatment of prostate and other cancers. Various classes of anticancer peptides were developed in his laboratory. Dr. Schally is the Professor of Pathology and Medicine at the University of Miami School of Medicine, Chief of the Endocrine, Polypeptide Cancer Institute at the VA Medical Center, Miami, Florida and Distinguished Medical Research Scientist. He has more than 2500 publications to his credit.

John E. Morley, MB, BCh, is the Dammert Professor of Gerontology, Director, Division of Geriatric Medicine and Director of the Division of Endocrinology at Saint Louis University School of Medicine. He serves as Medical Director for two nursing homes. Dr. Morley earned a medical degree at the University of Witwatersrand in Johannesburg, South Africa. He is board certified in Internal Medicine, Endocrinology and Geriatric Medicine. He has edited over 20 books, and published more than 1300 manuscripts. He has an h-factor of 107. He serves as Editor of Journal of the American Medical Directors Association, impact factor 6.61.

Dr. Erickson obtained her Ph.D. in Pharmacology and Physiology from Saint Louis University in Saint Louis, Missouri, U.S.A. She then completed postdoctoral training on neuroimmune communication at the University of Washington in Seattle, and studied neurodegenerative mechanisms in HIV-associated neurocognitive disorders and neurotoxicology of air pollution exposure during a second postdoctoral position at the University of Pennsylvania in Philadelphia. She is currently a Research Biologist at the VA Puget Sound Healthcare System and a Research Assistant Professor at the University of Washington. Dr. Erickson’s research focuses on how systemic inflammatory insults contribute to cognitive dysfunction, depression, and Alzheimer’s disease through interactions with the blood-brain barrier. Dr. Erickson has authored 33 non-abstract peer-reviewed publications that have collectively been cited over 1500 times.

George Anderson worked clinically for many years, mostly in psychiatry, but also in general hospital and general practice settings across the United Kingdom. He started his own research company namely CRC Scotland & London, based in London and at which he is Head of Research. His scientific interests have primarily been in CNS conditions and how these connect to wider body processes including the immune system and its regulators, such as the gut microbiome. He has published widely on the melatonergic pathway and mitochondrial function. He is involved in numerous collaborative projects with research groups across the world and has published over 150 research articles and book chapters.

Prof. Francesco Paolo Busardò obtained his Degree with honor in Medicine and Surgery at the University of Palermo (Italy), winning the Prize for the Best Thesis; he also got a MSc in Forensic Toxicology at the University of Glasgow (Scotland) and a PhD in Forensic Science at “Sapienza” University of Rome (Italy). He is currently Professor of forensic science and toxicology at University “Politecnica delle Marche” of Ancona, Italy. He is author of more than 150 papers with I.F., with a total I.F. higher than 400.

Dr. Cicero Arrigo is an Associate Professor at University of Bologna, Bolgna, Italy. He received his MD degree in 1998 from Alma Mater Studiorum University of Bologna, Italy and PhD degree from University of Siena, Italy in 2006. He then joined Alma Mater Studiorum University of Bologna, Italy as a post-doctoral fellow in 2007 and served until 2011. His research involves Mono- and multi-centre clinical trials on dietary supplements and drugs) and epidemiological studies. He has authored more than 450 full papers, published in reputed journals. He has membership and active role in different national and international scientific societies and is currently President of the Italian Nutraceutical Society (SINut), member of the national board of the Italian Hypertension Society.

Dr. Juan B. De Sanctis. Researcher at the Institute of Molecular and Translational Medicine. Palacky University, Czech Republic and Professor of Immunology and Biochemistry Institute of Immunology. Faculty of Medicine. Universidad Central de Venezuela. Member of FOCIS Center of Excellence in Immunology. PhD in Biochemistry and Immunology. Expertise in Inflammation, Metabolism, Flow Cytometry, Genetics, Pharmacology, and Immune response. Currently a member of the editorial board of Recent Patents on inflammation and allergy drug discovery. A reviewer of 25 different journals. Author of 150 publications. co-author of two patents.

Response: Jianxun Ding is a Professor at Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences (CAS). He received his B.S. degree from University of Science and Technology of China in 2007 and obtained his Ph.D. degree from CIAC, CAS, under the supervision of Prof. Xuesi Chen in 2013. During 2017 − 2019, he worked with Prof. Omid C. Farokhzad and Prof. Jinjun Shi from Harvard Medical School as a Postdoctoral Research Fellow. He has published more than 150 articles and applied for over 70 Chinese patents. His research focuses on polymer chemistry, controlled drug delivery, immunotherapy, and regenerative medicine.

Andrzej Grzybowski, M.D., Ph.D., MBA, is a Professor of Ophthalmology and Chair of Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland; Head of Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland. He is active in international scientific societies including AAO, EVER and European Academy of Ophthalmology. He has been an active editor, editor in chief and author of more than 550 peer-reviewed international publications, and over 50 book chapters; reviewer for more than 20 journals. He is an editor and co-author of many books, including Endophthalmitis in Clinical Practice, Current Concepts in Ophthalmology, OCT and Imaging in Central Nervous System Diseases.

Dr. Kovac obtained his degree from the Commenius University in Bratislava, Slovakia. He did research training at the Institute of Neuroimmunology of Slovak Academy of Sciences, Bratislava, Slovakia and University of Washington School of Medicine, Seattle, USA. He is currently senior research scientist at Institute of Neuroimmunology of Slovak Academy of Sciences. His main interest is in neurodegenerative diseases and blood-brain barrier. Dr Kovac published 36 non-abstract articles with over 500 citations according to Web of Science.

Dr. Hao Lin is a Professor of Center for Informational Biology at University of Electronic Science and Technology of China. He received his Ph.D. from Inner Mongolia University, P.R. China in 2007. His researches are focused on Bioinformatics and Systems Biology. He has published over 140 peer-reviewed papers in SCI-indexed journals. His publications have been cited over 8,000 times with H-index of 51 in Google Scholar (update in 2019.7). Homepage is http://lin-group.cn/ .

Dr. Domenico Di Raimondo is working as a professor of Internal Medicine and Sciences and Techniques of the Motor Activities at the University Of Palermo, Italy. He achieved a Postgraduate Specialization in Internal Medicine in 2005 and Ph.D. in 2008 from the University of Palermo respectively. He has published about 100 scientific papers in high-impact factor journals. His main research fields include arterial hypertension, blood pressure monitoring, vascular medicine, and exercise training.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at causes of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He has published more than 647 peer-reviewed research papers and registered 14 UK and International patents and is an editorial board member of 41 journals. He is currently the CEO of NanoRegMed Ltd, working on the commercialisation of his research. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguished Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world's first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalized graphene oxide for drug/gene/vaccine delivery.

Poonam Tandon is working as the Professor of Physics (Specialization in Experimental Solid State Physics), University of Lucknow, India. She received M.Sc. and Ph.D. from University of Lucknow, India in 1989 and 1992, respectively. She has published more than 200 scientific papers. Her research covers structure property correlation in pharmaceutical compounds. structure and dynamics of polymers, nanomaterials and their applications. She supervised the Ph.D. thesis of 37 students. Prof. Tandon is recipient of several international and national awards/ fellowships, to name a few Alexander von Humboldt Fellow; Regular Associate, International Centre for Theoretical Physics, Italy; Fellow, International Union for Pure and Applied Chemistry; JSPS, Japan Fellowship; Member, Scientific Committee of World Forum for Advanced Materials; Fellow, Asia Pacific Academy of Materials; Young Scientist Award, UP State Government; MRSI-Medal, Materials Research Society of India; UGC Research Award.

Dr. Tiwari received his Bachelors's in Pharmacy from India, followed by Masters and Ph.D. in Cancer Pharmacology from St. John’s University, NY. He did his Post-Doctoral training from Mount Sinai School of Medicine, NY. As an Associate Professor in the Department of Pharmacology and Experimental Therapeutics at the College of Pharmacy at UT, he directs the Cancer and Systems Therapeutics program. Dr. Tiwari’s cancer pharmacology lab is focused on designing, characterizing (i.e. PK/PD) and developing targeted anticancer molecules against advanced multidrug-resistant cancers. In these areas, Dr. Tiwari holds 5 patent applications, has authored 105 peer-reviewed articles and presented over 150 presentations in national and international conferences. Dr. Tiwari is an Associate Editor for Frontiers in Pharmacology and is on the Editorial Board of several journals including the Journal of Clinical Medicine and Oncology Reports. Dr. Tiwari’s research is supported by grants from federal agencies, International agencies, Private Foundations, and Pharmaceutical companies.

Many neurological disorders remain untreatable and continue to cause incalculable losses to productivity, independence, and overall quality of life among patients globally. Currently available approaches to the treatment of ischemic stroke and traumatic brain injury do not adequately meet clinical and social demands. Discovery and development of drugs with clinical efficacy presents tremendous intellectual and commercial challenges. Dr. Uteshev was trained as a neuro-pharmacologist and his lab focuses on developing novel therapeutic strategies and pharmacological tools to treat ischemic stroke, traumatic brain injury, chronic neuropathy, and other challenging neurological disorders linked to brain injury and inflammation. The primary focus is the cholinergic system and α7 nicotinic acetylcholine receptors (nAChRs). These receptors are commonly expressed throughout the body including neuronal, glial, and immune tissues. A balanced activation of α7 nAChRs inhibits inflammation and elevates brain resistance to ischemic and traumatic injury. Accordingly, whenever a brain injury occurs, two simultaneous processes are automatically initiated as the injury stimulates α7 nAChRs: first, the brain tissue near the site of injury becomes protected from spreading injury; and second, the injury-induced inflammation is mitigated to prevent additional injury by the immune system. Positive allosteric modulators (PAMs) and selective agonists of α7 nAChRs hold considerable promise as potential stroke and TBI treatments. PAMs augment α7 activation by endogenous agonists, choline, and ACh, allowing for a gentle modulation of immune response and recovery from injury.

Dr. Hanting Zhang is currently a tenured faculty at the Rockefeller Neuroscience Institute, West Virginia University Health Sciences Center. He received his Bachelor/M.D. from Southern Medical University (formerly the First Military Medical University) in Guangzhou and M.S./Ph.D. of Pharmacology from Beijing Institute of Pharmacology & Toxicology, China. He was a postdoctoral fellow first at Louisiana State University Health Sciences Center in Shreveport, LA and then at University of Tennessee Health Science Center in Memphis, TN. Dr. Zhang’s research focuses include identification of CNS functional roles of cyclic nucleotide phosphodiesterases (PDEs), in particular PDE4, and intracellular signaling in the mediation of neurodegenerative and neuropsychiatric disorders. Dr. Zhang has published more than 100 research papers and review articles and 18 book chapters, in addition to a book entitled “Phosphodiesterases: CNS Functions and Diseases” published by Springer (2017; 471 pages), in which he serves as the Editor-in-Chief. Dr. Zhang currently serves as the Deputy Chief Editor/Associate Editor for 8 journals and Editorial Board member for several other journals.

Dr. Jian Zhong is currently an Associate Professor at Shanghai Ocean University. He received his bachelor's degree in Pharmaceutics from Shenyang Pharmaceutical University in 2002 and his Ph.D. degree in Biomechanics and Medical Engineering from Peking University in 2007. Then, he worked as a Postdoc (2007-2010) at University College Dublin, Ireland. He was also a Visiting Scholar (2007-2008) of Purdue University. After that, he acted as an Associate Professor in the National Engineering Research Center for Nanotechnology (2011-2015). He is a Senior Visiting Scholar (2016-2017) in the Institute of Chemistry, Chinese Academy of Sciences. He was elected as Shanghai Pujiang Talent (2012) and Minhang District Leading Talent (2011). His research interests include Food Safety and Nutrition, NanoBiomedical Engineering. He has published more than 80 SCI papers. He has applied for more than 50 national patents (20 authorized national invention patents). He published four English books and three Chinese books.

He is currently Professor, Head of the Department of Chemistry and Biochemistry and Vice-Rector of Research and Innovation, Mendel University in Brno. He has obtained Ph.D. In the field of Cellular and Molecular Biology at Masaryk University. He has acted as a principal for more than a dozen of national projects, one project of the 7th Framework Program and three H2020 projects including ERC Starting Grant. He is chairman of the editorial board of Acta Universitatis Agriculturaeet Silviculturae Mendelianae Brunensis. From scientometry perspective, he has authored more than 500 ISI indexed documents with over 9000 citations and h-Index 47.

Dr Aijaz Ahmad is a Senior Medical Scientist in the division of Infection Control of National Health Laboratory Service at Charlotte Maxeke Johannesburg Academic Hospital and a Lecturer in the Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand. He has obtained his Ph.D. in Medical Mycology. During his trainings as a Postdoctoral Scientist from the Wits Oral Biological Sciences, Tshwane University of Technology Pharmaceutical Sciences, All India Institute of Medical Sciences and International Clinical Epidemiology Network, he gained lot of experience to be a medical microbiologist. He is an NRF rated Scientist, with an extensive research experience in infectious diseases, microbial pathogenesis and drug development. He has over 60 peer-reviewed publications and is recipient of several grants and awards.

Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.

Dr. Yochai Birnbaum received his medical education from Hadassah Medical School, Hebrew University, Jerusalem in 1974. He received post graduate training from various institutions including Research fellowship at University of Southern California, Los Angeles, California in 1996. Currently, he is Professor of Medicine at Baylor College of Medicine and Professor of Biochemistry and Molecular Biology at University of Texas Medical Branch, Texas.

Dr. Monica Butnariu completed her Ph.D. in 2005 from Banat University, Romania. In 2013, she became a habilitated doctor from Cluj-Napoca University, Romania. She is a professor at the University of Agricultural Sciences and Veterinary Medicine of Banat "King Mihai I of Romania" in Timisoara, Romania (Chemistry & Biochemistry Discipline). Dr. Butnariu has numerous articles published in the Science Citation Index (SCI), International Scientific Indexing (ISI), Web of Science Core Collection, and Clarivate Analytics that have been cited over 1200 times, and her publication H-index is 32 (Citation Metrics WoS). She has been serving as an editorial board member of some reputed journals and is also involved in peer review activities. So far, she has written several books and book chapters on different areas of chemistry. In addition, she has received the Romanian Academy Award for chapter ‘Chemical Composition of Vegetables and their Products’ in the Handbook of Food Chemistry (http://www.acad.ro/premiileAR/liste/2014.pdf). Currently, she is the head of CONEM Romania Biotechnology and Environmental Sciences Group, and also the National Correspondent of the International Association for Plant Biotechnology.

Dr. Antoni Camins is a Professor in the Department of Pharmacology Toxicology and Therapeutic Chemistry at Barcelona University (Faculty of Pharmacy and Food Sciences). He obtained his PhD from University of Barcelona and received postdoctoral training at Novartis Switzerland. Dr. Camins research focuses on Alzheimer’s disease, Epilepsy and neurodegeneration. He is also interested in drug treatment, pharmaceutical nanoparticles drug delivery systems. He is involved in projects aimed at the synthesis and development of new potential compounds for the Alzheimer’s disease D treatment. He is author of more than two hundred scientific articles published on international peer-reviewed journals, with h-index = 45.

Prof. Fei Chen did Medicine from Nantong Medical College, P.R. China in 1982 and PhD in Immunology, Peking University Health Science Center, P.R. China in 1994. He is currently a Professor at Department of Oncology, Karmanos Cancer Center, Wayne State University, MI. He has numerous honors/awards for his contributions to science overall.

Giuseppe Cirillo received his degree in Pharmaceutical Chemistry and Technology cum laude in 2005 and the PhD in Methodologies for the Development of Molecules of Pharmaceutical Interest in 2008 from University of Calabria. He was visiting researcher at Leibniz Institute for Solid State and Materials Research Dresden (Germany), establishing scientific cooperation with research groups from Germany, Spain, Australia and Italy, in a multidisciplinary consortium working on biomedical applications of polymer therapeutics, and hybrid nanocarriers. He authored more than 110 publications, including research articles, review articles and invited book chapters. He was invited speaker at different international conferences/meetings.

Prof. Magali Cucchiarini is a Sciencetific Dr. of Life sciences (or biology doctor of natural sciences). In which she has done a PHD from the University of Nice-Sophia Antipolis in France, also been part of Laboratory of Virology. She is a Group Leader at Center of Experimental Orthopaedics, Saarland University. Her particular scientific and research interests are the understanding and treatment of human degenerative diseases by gene-, cell-, and tissue engineering-based translational approaches with a particular focus on disorders that affect the musculoskeletal system. Her Scientific Collaborations at an International level with Prof. Dr. L. Lebeau, Prof. Dr. F. Pons and Prof. Dr. M. Garcia-Fuentes. Dr. Cucchiarini has 81 original publications, 41 reviews, and has reviewed for Academic Positions in 2017 as the Member of Jury of Evaluation of Research Center, University of Strasbourg, France.

Gerardino D’Erricois associate professor of Physical Chemistry at the Department of Chemical Sciences of the University of Naples Federico II. His scientific research is aimed at the spectroscopic characterization of the supramolecular aggregates formed by natural lipids and of their interactions with peptides and proteins. In this framework, he is currently investigating relevant biological processes involving biomembranes, such as the viral fusion and the b-Amyloid self-aggregation. Besides the fundamental understanding, he is investigating the mechanism of action of pharmaceutical actives, aiming at the design optimization. Gerardino D’Errico is author of about 130 scientific publications on international journals.

Dr. Jianxun Ding is an associated professor in Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences (CAS). He received his B.S. degree from the University of Science and Technology of China (USTC) in 2007 and then obtained his Ph.D. degree from CIAC, CAS in 2013. He was awarded the 2012 President's Excellence Award from CAS among more than 10 other awards. He has published over 150 academic papers in high-impact journals and has applied for over 60 Chinese patents. His research interests focus on synthesis of functional biodegradable polymers for drug delivery, immunotherapy, and regenerative medicine.

Dr. Efird received his PhD from Stanford University. He is currently Director, Centre for Clinical Epidemiology and Biostatistics at the University of Newcastle, Australia. His areas of interest include catecholamines, monoamine oxidase-B, GSH-peroxidase, inotropes, nitrates, PDE-3 inhibitors, and antiplatelet agents.

Professor Daiming Fan is the member and past vice president of Chinese Academy of Engineering, foreign associate of the USA National Academy of Medicine, president of Chinese Anti-Cancer Association, and vice president of Asian Pacific Association of Gastroenterology, past president of Fourth Military Medical University, past president of Chinese Society of Gastroenterology, director of Xijing Hospital of Digestive Diseases and State Key Laboratory of Cancer Biology. As the congress president, he successfully organized the GASTRO2013 (WCOG/APDW) in Shanghai. As the first or corresponding author he has published more than six hundred papers on the international journals, such as Nat Med, Nat Rev Gastroenterol Hepatol, Nat Clin Pract Oncol, Lancet, Gut, etc.

Dr. Ferrante obtained his Medical degree from Catholic University of the Sacred Heart (Rome, Italy) in 2001. He is specialized in Cardiovascular Disease with honors at Catholic University of the Sacred Heart (Rome, Italy) in 2006 and got his Ph.D. in Cellular and molecular Cardiology from Catholic University of the Sacred Heart (Rome, Italy) in 2010. He is currently senior interventional cardiologist at the Department of Cardiovascular Medicine, Humanitas Research hospital (Rozzano, Italy), and adjunct Professor at Humanitas University (Pieve Emanuele, Italy). His main research interests are the mechanisms of acute coronary syndromes, drug-eluting stents, antiplatelet therapy and evidence based medicine. He has published more than 70 peer-reviewed scientific papers.

Prof. Stefano Fiorucci, is professor of Gastroenterology at University of Perugia, is the author of over 350 full papers.He is the director of gastroenterology unit of the Department of Surgical and Biomedical sciences.

I am currently Full Professor and Chair of Human Anatomy at the University of Pisa, and Team Leader of Neurobiology of Movement Disorders at IRCCS Neuromed. I had been trained at University of Pisa, Italy, Georgetown University, Washington (D.C.),University of Washington, Seattle (WA). At the University of Pisa I completed my M.D. course and I received a Ph.D degree in Medical sciences at SSSUP S. Anna. I worked as Post Doctoral Fellow while finishing the residency in Clinical Pharmacology. My expertise in neurodegeneration, witnessed by over 200 peer-reviewed publications, encompasses alteration of autophagy in motor neuron disease.

Nigel H. Greig (Ph.D. Pharmacology, University of London, England) heads the Drug Design & Development Section within the Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health. Located in Baltimore, MD, USA, his program combines cellular, molecular and in vivo pharmacology with medicinal chemistry to design and development novel experimental drugs against rate-limiting steps involved in the pathophysiology of diseases associated with aging, with an emphasis on the nervous system. Nigel, together with his exceptional collaborators and research group have successfully moved multiple experimental drugs from concept through preclinical studies and into human clinical trials.

He is currently Professor in the Department of Pharmaceutical Chemistry, Sri Sai College of Pharmacy and Director-Research & Development, Sri Sai Group of Institutes, Badhani, Pathankot, India. He has obtained Ph.D. in the field of Pharmaceutical Sciences at Maharishi Markandeshwar (Deemed to be University) Mullana, India. He is also a member of many pharmaceutical associations and scientific societies. He is also an editorial board member, editor, guest editor and reviewer of many reputed international and national journals. From scientometry perspective, he has authored more than 100 ISI indexed documents with over 1000 citations and h-Index 19.

Prof. (Dr.) Khalid Rehman Hakeem, PhD is Professor at King Abdulaziz University, Jeddah, Saudi Arabia. He has more than 10 years of teaching and research experience in molecular biology, plant ecophysiology and medicinal plant research. Dr. Hakeem has authored and edited more than 50 books with international publishers, including Springer Nature, Academic Press (Elsevier), and CRC Press. He also has to his credit more than 110 research publications in peer-reviewed international journals and 60 book chapters in edited volumes with international publishers.

Dominique Heymann is Professor of Histology and Embryology at the University of Nantes (France). From 2004 to 2016He was the head of a joint research unit recognized by INSERM and the University of Nantesdedicated to the pathogenesis of bone sarcomas. From 2015, Hehas joined the Department of Oncology and Metabolism at the University of Sheffield (UK). Since 2017, Dominique Heymann is now Professor at the Integrated Cancer Centre (Nantes, FR) and honorary-Professor at the University of Sheffield. He has authored more than 240 publications in peer-reviewed journals mainly in the field of bone cancer and osteoclast differentiation.

Dr. Emilio Hirsch is Full Professor of Biology at the Department of Molecular Biotechnology and Health Sciences, University of Turin. He is author of 227 publications, and his contributions have received around 15000 citations and he has an h-index (Google Scholar) of 70. Dr. Hirsch has numerous awards/honors and internationally recognized scientific publications to his credit.

Dr. Hou obtained a doctorate (Ph.D.) in Computational Chemistry from Peking University in 2002 and is currently the professor for College of Pharmaceutical Sciences at Zhejiang University in Hangzhou. His research focuses on development of new methods for computer-aided drug design (CADD) and design of potential lead compounds for important drug targets. He has published more than 260 peer reviewed papers in international prestigious SCI-cited journals, 4 book chapters and 1 multimedia courseware.

Dr. Richard A. Houghten, Ph.D., is the Founder, President and CEO of Torrey Pines Institute of Molecular Studies, Port St. Lucie, FL, USA. Over the past 30 years, he has focused his scientific efforts toward the development and use of a series of interlocking and powerful hit/lead/probe discovery platform techniques (parallel synthesis techniques and combinatorial chemistry). His strengths are in inventing and developing novel and far/wide ranging approaches for use in existing discovery problems. As an author/co-author, Dr. Houghten has more than 475 publications to his credit (having a very significant number of total citations, i.e. over 23,980), 75 issued US patents and 45 issued foreign patents.

Prof. R. Jayakumar is working at Amrita Centre for Nanosciences and Molecular Medicine (ACNSMM), Amrita Institute of Medical Sciences and Research Centre, Kochi-682041, specializing in the area of Biomaterials for Healthcare Applications. Dr. R. Jayakumar joined ACNSMM in November 2007. He received his Ph.D. in Polymer Chemistry from Anna University, Chennai, India (2002). Dr. Jayakumar's research laboratory at Amrita Centre for Nanosciences and Molecular Medicine is mainly interested in the development of biodegradable polymeric nanofibers, nanogels, nanoparticles, nanocomposite scaffolds and injectable hydrogels for Tissue engineering, Drug Delivery and Wound Dressing applications.

Dr. Xiqun Jiang is currently a professor of Department of Polymer Science & Engineering in College of Chemistry & Chemical Engineering at Nanjing University, P. R. China. He received his B.S. degree and MS degree in Polymer Chemistry at Nanjing University and got Ph. D at Nanjing University as a co-training Ph. D. student of Kyushu University, Japan and Nanjing University. His Post-Doctoral work was done at University of Wisconsin-Madison. His current research interest is focused on nanomedicine, drug delivery systems, macromolecular drug and polymer-based imaging probes. He has authored or co-authored more than 150 peer-reviewed articles, with 15 patents.

Ranjith K. Kankala is currently working as Associate Professor at Huaqiao University, P. R. China. After receiving his B.S and M.S in Pharmaceutical Sciences and Ph.D. degree in the field of nanomedicine, he then joined as faculty at Huaqiao University. He has authored over 85 international peer-reviewed publications (Google Scholar: YL8aDgsAAAAJ) in various journals in the fields of Biomaterials, Pharmaceutical Sciences, and Chemistry. He also acts as a referee for top-ranked journals like Nature communications and many journals in his area of expertise. His expertise relates to the preparation of cutting-edge multifunctional nano-/micro- hybrid systems with optimized properties for innovative biomedical applications.

Alireza Karimi received his Ph.D degree in Mechanical Engineering/Bioengineering from Kyushu University, Japan. His primary area of interest is ocular biomechanics. He is the author of more than 130 peer reviewed articles in the international journals.

Keith W. Kelley is a Professor Emeritus of Immunophysiology at the University of Illinois. Dr. Kelley earned his Ph.D. in 1976, a time when the immune system was considered only to protect against infectious diseases. He helped reshape that view by bringing physiology to immunology. It is now accepted that there is an active dialogue between the immune system and brain, and these discoveries are improving human and animal health. Professor Kelley has been honored with 10 university and national awards, published more than 250 peer-reviewed scientific papers as well as 70 book chapters, is well cited with an h-index of 68, been funded for 50 years as the Principal Investigator of NIH grants and served on four dozen NIH study sections. He is currently a Full Member of the Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section. Dr. Kelley is a Past-President and Secretary-Treasurer of the PsychoNeuroImmunology Research Society. He has been Editor-in-Chief of Brain, Behavior, and Immunity since 2003. The latest impact factor of the journal is 5.9, ranking it in the top 14% of all immunology journals and 11% of neuroscience journals.

Dr. Alexander Kornienko did B.S in Chemical Engineering from Mendeleev University, Moscow, Russia in 1994 and Ph.D. in Chemistry from Tufts University, Boston, USA in 1999. Since 2012, he has been associated with Texas State University and became a Professor at the Department of Chemistry and Biochemistry in 2016. His areas of interest are (a) Synthetic Organic Chemistry (b) Chemical Biology (focus on cancer signaling and death pathways) (c) Medicinal Chemistry (rational drug design and library screening) (d) Natural Product Chemistry (isolation, structure elucidation and analogue synthesis). Dr. Kornienko has numerous publications and honors to his credit.

Dr. Yoongho Lim is currently a Professor in the Division of Bioscience and Biotechnology at Konkuk University, Seoul, South Korea. His research skills and expertise mainly lie in the subject areas of Cell Biology, Molecular Biology, Cancer Research, Genetics, Immunology, Endocrinology, Developmental Biology, etc. Dr. Lim, as an author/co-author, has published more than 275 articles in various journals, having a significant number of total citations, i.e. over 3,680.

Luisa Carlota Lopez-Cara received a Ph.D. in Pharmaceutical Sciences. She has done Post-Doctoral Fellowship from the Department of Pharmaceutical Sciences of the University of Ferrara and Department of Chemistry of Emory University. Currently, she is a Researcher and Associate Professor in the Department of Medicinal and Organic Chemistry of the University of Granada. She was engaged in the study of bioactive molecules with antiproliferative and antiangiogenic effects. Her research interests concern the design, synthesis and SARs study of new molecules endowed with antiproliferative activity both in vitro and in vivo and in particular of the mechanisms that lead to cell death. She is author of about 75 scientific papers in qualified peer-review journals. She is a holder of many Spanish and European patents concerning the antitumoral molecules.

Tong-Bu Lu (1964) obtained B.S. in 1988 and Ph.D. in 1993 under the supervision of Prof. Min-Yu Tan from Lanzhou University. After two years postdoctoral fellowship at Sun Yat-Sen University, he joined the faculty at the same University, and became a professor in 2000. In 1998 and 2002, he works as a postdoctor in F.A. Cotton’s group at Texas A&M University. He moved to Tianjing University of Technology in 2016. His research interest is crystal engineering, including macrocyclic chemistry, MOFs and pharmaceutical polymorphs and cocrystals. He has over 200 scientific publications, with H-index 43.

Guanghui Ma, Ph.D, Professor. She graduated from Gunma University of Japan in 1988, received Ph.D degree from Tokyo Institute of Technology in 1993. She joined in Tokyo University of Agriculture and Technology as an assistant professor from 1994, and became a professor of Institute of Process Engineering, Chinese Academy of Sciences since 2001. She is a winner of the Outstanding Young Scientists Fund (2001). More than 300 SCI articles published, such as Nature Materials, Nature Communication, JACS, Adv. Mater., Adv. Funct. Mater.80 patents were authorized. She was awarded as China “Outstanding Women Scientist” (2005).

Dr. Giuseppe Maina graduated (summa cum laude) in Medicine and Surgery from the University of Turin, Italy in 1985 and Specialized in Psychiatry with honors in 1989. Since 2014, he is Director of the Psychiatric Unit, University Hospital San Luigi Gonzaga, Orbassano - Medical School of the University of Turin. Dr. Maina main research interests include (a) Clinical Psychiatry and Clinical Psychopharmacology (b) Brief Dynamic Psychotherapy (c) Obsessive-Compulsive Disorder (d) Bipolar Disorders.

Dr. McMillan earned a Ph.D. in Toxicology from Texas A&M University, College Station, TX, USA. She held a post-doctoral fellowship at the National Center for Toxicological Research, Jefferson AR, USA, and a second post-doctoral fellowship in the Department of Pharmacology and Experimental Therapeutics, College of Medicine, at the Medical University of South Carolina, Charleston SC, USA. She remained at the Medical University of South Carolina as an Assistant Professor in the Pharmacology Department and then moved to the University of Nebraska Medical Center, Omaha, NE, USA, in 2007. She holds a joint appointment in the Department of Pharmacology and Experimental Neuroscience, College of Medicine, and the Department of Environmental, Agricultural and Occupational Health, College of Public Health. She has authored/coauthored over 70 scientific publications and book chapters.

Dr. Jose Medina-Franco received a Bachelor of Science degree in chemistry from the National Autonomous University of Mexico.In 1998he joined Procter & Gamble. He received Ph.D. degree in 2005, both from the UNAM.He joined the University of Arizona as a postdoctoral fellow. Dr. Medina-Franco was named Assistant Member at the Torrey Pines Institute for Molecular Studies in Florida where he worked as PI for 5 years.He conducted research in drug discovery at the Mayo Clinic. Dr. Medina-Franco is currently Full Professor at the School of Chemistry at UNAM where he leads the research group DIFACQUIM.

Dr. Paola Mura is a Full Professor of Pharmaceutical Technology at Department of Chemistry, School of Human Health Sciences, University of Florence. Her academic background consist of studying pharmacy and pharmaceutical chemistry from Faculty of Pharmacy, University of Florence (1971-1976). She is Author of more than 180 Publications on known and qualified Scientific Journals and more than 230 Communications to national and international Congresses. Dr. Mura’s main research interests are aimed at drug optimization in pharmaceutical formulations (for improving its efficacy, stability and safety) and at the development of innovative dosage forms (for obtaining controlled and/or targeted drug release) in order to achieve safer and more effective drug utilization.

Dr. Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel, specializing in Internal Medicine and Haematology at the Rambam Medical Center, Haifa, and in Hematopoiesis (MSc) in TA University, Israel. During 1986 to 1990, he carried out a Postdoctoral research fellowship in haematology and bone marrow transplantation at "Stanford University Hospital" Palo Alto, CA, USA.  Dr. Nagler has been working in the fields of bone marrow transplantation for haematological malignancies, for the last 25 years. Dr. Nagler is one of the pioneered of the non myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders.

Dr. Kazufumi Nakamura did Medicine from Okayama University Medical School, Okayama, Japan in 1993 and PhD from Okayama University Graduate School of Medicine, Okayama, Japan in 1998. Since 2013, he is an Associate Professor at Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine. Dr. Nakamura has been bestowed numerous honors and awards for his contribution to medical science over the years.

Ali Nokhodchi is a professor of pharmaceutics and drug delivery at The University of Sussex, School of Life Sciences. Professor Nokhodchi has obtained his PharmD from Tabriz University of Medical Sciences, Iran (1989) and Ph.D. from Liverpool John Moores University, UK (1996). His ongoing research topics include particle engineering, Pulmonary drug delivery, 3D printing, Hot Melt Extrusion, nanotechnology, and dissolution enhancement of poorly water-soluble drugs. Professor Nokhodchi has published over 250 peer-reviewed research articles, a book on pulmonary drug delivery and 6 book chapters in various filed of pharmaceutics. He is associate editor and editorial board member of over 10 international pharmaceutical journals.

Ruth Nussinov graduated from Rutgers, was in the Weizmann Institute, the Chemistry Department at Berkeley and Biochemistry at Harvard. She joined the Medical School in Tel Aviv and accepted a concurrent position at the National Cancer Institute, Leidos. She has co-authored over 550 papers. She is the Editor-in-Chief in PLoS Computational Biology, and an Associate Editor and on the Editorial Boards of several journals. She is a frequent speaker in Domestic and International meetings, symposia and academic institutions, won several awards and elected fellow of several societies. Her National Cancer Institute website describes her science, and major contributions. https://ccr.cancer.gov/ruth-nussinov.

Dr. Emmanuel C. Opara is a Professor at Institute for Regenerative Medicine, VT-Wake Forest School of Biomedical Engineering & Sciences (SBES) Center on Diabetes, Obesity & Metabolism, Wake Forest School of Medicine. He did B.Sc. (Hons) in Biochemistry from University of Nigeria in 1976 and M.Sc. in clinical biochemistry from University of Surrey in 1980. Furthermore, he did PhD from University of London, England in 1983.

In 1971, Dr. Gian Maria received Laurea (Highest degree of Italian University) in Biological Sciences from University of Pisa. After that in 1983, Dr. Gian earned PhD in Medical Science from Karolinska Institute, Huddinge University Hospital. Dr. Gian was an Associate Professor of Pharmacology at Medical School, University of Pisa, Italy. Dr. Gian’s main scientific interest is in Neonatal clinical pharmacology. Dr. Gian is also a member of many international journals such as Journal of Pediatric Biochemistry, Jacobs Journal of Drug Metabolism and Toxicology, Current Pharmaceutical Design and so on.

He graduated in Medicine in 1988. In 1994 he received a doctorate in Cardiovascular Physiology. From 1996 to 1999 he worked at Johns Hopkins University, as a researcherand as a visiting scientist.Prof. Pagliaro has received numerous honors, prizes and awards. He is a member of the following scientific societies: Italian Society of Physiology, Physiological Society and Italian Cardiovascular Research Society. He is President of the SIRC, vice-chair of the Cardiotoxicity and Cardioprotection SIC working-group, and vice-chair of the PhD program in Experimental Medicine and Therapy.He published more than 150 peer-reviewedarticles. On Scopus, h-index is 33.

Dr. Luna graduated in Pharmacy in 1986 and obtained her Ph.D. in 1992. She is a regular teacher of): Pharmaceutical Technology, Socio economy and Law for Industrial Pharmacy degree (II level), University of Perugia (Dept. of Pharmaceutical Sciences). She is author of many research papers published mainly on international journals. Her skills and expertise are in Thin Films and Nanotechnology, Materials Chemistry, Spectroscopy, Nanotechnology, Pharmacokinetics, Nano biotechnology, and Pharmaceutics and Pharmaceutical Technology. She has contributed more than 150 publications, having citations around 2,630

Dr. Rosario is presently serving as a Full Professor at the Department of Drug Sciences, University of Catania. He has contributed more than 160 publications, having citations around 3,106. His research interests are Nanoparticles, Nanotechnology, Pharmaceutics and Pharmaceutical Technology, Thermal Analysis, Polymer Chemistry, Pharmacy, Controlled Drug Delivery and Drug Formulation.

Dr. Priebe obtained a Master of Science in Organic Chemistry degree from the University of Warsaw in Poland and a doctorate (Ph.D.) in Organic and Medical Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences in Poland. He is a Professor of Medicinal Chemistry at The University of Texas M. D. Anderson Cancer Center in Houston and also holds the title of Professor of Chemistry in the Republic of Poland. Prof. Priebe is noted for his successful development of new therapeutic entities for the treatment of cancer. Five of his drugs entered clinical trials and several others are in different stages of preclinical development. He has published more than 200 scientific publications and his work has led to over 50 patents.

In revision of my research accomplishments, the researcher emphasizes his experience in Food Chemistry and Technology having published more than 75 peer-reviewed articles (SCI journals), with more than 1600 citations and h-index of 24. The researcher has strongly collaborated in 23 different types of research project funds as team member (6 international, 6 European, 7 national, 2 regional and 3 company contracts). Moreover, he holds 5 patents and another one has been recently submitted. The researcher has participated in 102 national and international conferences in different fields of study from Food Technology to Mathematical/Statistical Sciences. He has acquired teaching experience at the University of Vigo lecturing Experimental Science subject since 2017. As demonstrative example of the internationalization of the research career, the 75 articles have been accomplished in collaboration with a total of 21 world-wide recognized institutions. Currently, he is member of the editorial board of Frontiers in Bioscience (Landmark Edition) as managing editor of a special issue and guest editor in Scientific World Journal.

ZhiYong Qian, Professor in the State Key Lab of Biotherapy, West China Hospital, Sichuan University, the National Distinguished Young Scholar, was born in January 1976 in Jiangsu Province, PR China. Dr. Qian obtained his PhD from the Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences at 2003. His research interests are in the area of biomaterials, biomedical engineering, drug delivery system, tissue engineering and nanotechnology. He has published more than 100 papers in peer-reviewed journals. Prof. Qian is the Editor-in-Chief of “J Biomed Nanotechnology”, Associate Editor of “Chinese Chemical Letters”.

Dr. Nima Rezaei did his M.D. from School of Medicine, Tehran University of Medical Sciences in 2002. He did M.Sc. and PhD from School of Medicine and Biomedical Sciences, The University of Sheffield in 2006 and 2009. He has more than 640 articles publications in the internationally recognized scientific journals (H-index: 50). Over the years, Dr. Rezaei has presented more than 400 lectures/posters in international and national congresses.

Dr. Prof. Rita Rezzani has been serving as a chairman and a full professor of Anatomy and Physiopathology Division at the Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy since 2006. Her skills and expertise are in Cell Culture, Hypertension, Apoptosis, Inflammation, Atherosclerosis, Antioxidants, Blood Pressure, Reactive Oxygen Species, Oxidative Stress and Free Radical Scavengers. She has contributed more than 250 publications in different international journals and she has been cited more than 5000 times in different publications.

Dr. Carlo Riccardi obtained his Medical degree in 1988 from Perugia University Medical School, University of Perugia, Italy. Dr. Riccardi is currently Full Professor of Pharmacology, in the Department of Medicine, at Perugia University Medical School, University of Perugia. His skills and expertise mainly lie in the subject areas of pharmacology, drug therapy, inflammation, autoimmunity, immunopharmacology, inflammatory and autoimmune diseases, anti-inflammatory drugs, etc. Dr. Riccardi, as an author/co-author, has published more than 285 articles in various journals, having a significant number of total citations, i.e. over 13,390.

Silvia Rivara is Associate Professor of Medicinal Chemistry at the Department of Food and Drug of the University of Parma (Italy). Her scientific interests are focused on drug design and structure-activity relationship studies. She has participated to the design and development of several new compounds acting on drug targets, mainly GPCRs and enzymes. Computational techniques, like virtual screening, molecular dynamics, pharmacophore building etc. are applied to support lead finding and optimization. She is also involved in projects aimed at the development of protein-protein interaction inhibitors and of dual-acting compounds. She is author of more than one hundred scientific articles published on international peer-reviewed journals, with h-index = 30.

Prof. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy as well as Associate Professor of Internal Medicine at the School of Medicine, University of South Carolina, USA. Prof. Rizzo sits on the editorial board of 9 international journals with Impact Factor. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-lowering and anti‐diabetic agents) and basic research (focus on novel cardiovascular risk factors), with 200+ scientific publications with Impact Factor (total Impact Factor: >700. H‐Index: 42).

Prof. Matteo A. Russo obtained his Medical Degree from Catholic University Medical School in Rome (Italy). He specialized in Oncology, General Pathology (from University of Rome Sapienza) and Cardiology (Catholic University Medical School). Soon after he got a track tenure at University of Rome Sapienza Medical School, first, as Associate Professor of Experimental Oncology and then as Full Professor of General Pathology. At present, he is the Head of Basic Research and Laboratories at San Raffaele Scientific Institute; he is also President of MEBIC (Medical and Experimental Bioimaging Center, a joint consortium between San Raffaele University and University of Rome Tor Vergata). He has published more than 150 scientific papers, being awarded by three international prizes for Basic Research. Prof. Russo is member of the editorial board of 6 peer-reviewed journals.

Andrew V. Schally, Ph.D., M.D.h.c., received his training in England, Canada, Sweden, and USA. In the years 1954-1977 he worked in the field of neuroendocrinology. Dr. Schally’s group isolated and elucidated the structure of hypothalamic LHRH. Dr. Schally was awarded the Nobel Prize in Medicine in 1977 for his work on hypothalamic peptides. Dr. Schally switched then to cancer research. He is a world leader in research on hormone-related cancers and treatment of prostate and other cancers. Various classes of anticancer peptides were developed in his laboratory. Dr. Schally is the Professor of Pathology and Medicine at the University of Miami School of Medicine, Chief of the Endocrine, Polypeptide Cancer Institute at the VA Medical Center, Miami, Florida and Distinguished Medical Research Scientist. He has more than 2500 publications to his credit.

My research interests are comparative placental and reproductive physiology in normal and pathological pregnancies; materno-placental-fetal interaction in maternal obesity, maternal alcohol and marijuana consumption, pre-eclampsia and racial discrepancies and mechanism of developmental programming in these conditions. In utero fetal brain protection, and placental stress, transport and synthesis of lipid derivatives (endocannabinoids), lipid-soluble vitamins and hormones in adverse maternal environment. I am interested in development of non-invasive methods of diagnosis of placental pathologies. I am developing the novel direction, studying the mechanism of host-microbial interaction in fetal and place development.

Javad Sharifi-Rad is Research Scientist in Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. His main topics of study and research interests have been phytochemistry, medicinal chemistry and biological activities of natural products. He is component of the board of editors of several reputable international journals and several scientific societies. He has authored over 250 publications and so many international and national conference papers about biological activities of medicinal plants and natural products.

Dr. Jasvinder A. Singh, MD, MPH, is currently serving as a Professor of Medicine and Epidemiology at University of Alabama at Birmingham. He is also a Staff Physician at University of Alabama Hospital and University, Veterans Affairs (VA) Medical Center, Cooper Green Mercy Hospital, and UAB Highlands Hospital. He has been recognized with Max Cooper Award for Research Excellence in 2017, Henry Kunkel Young Investigator Award in 2016, and American College of Rheumatology (ACR) Rheumatology fellow award in 2001. He has contributed more than 600 publications, having citations around 35,311.

Dr Claudio Soto is Professor of Neurology and Director of the Mitchell Center for Alzheimer’s disease and related Brain Disorders at the University of Texas in Houston. He received his PhD from the University of Chile in 1993. His research focuses in understanding the molecular basis of neurodegenerative diseases associated to the misfolding and aggregation of proteins, particularly Alzheimer’s and prion disorders. He has published more than 160 peer review articles, many of which have been published in prestigious scientific journals (including Cell, Nature, Science, New England Journal of Medicine, Nature medicine, Lancet, etc). Dr Soto's publications have been cited more than 12,000 times (H index 59). He has been awarded many grants from NIH, and private foundations for a total funding of over 30 million dollars, and has been invited speaker in more than 160 scientific meetings worldwide.

is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).

Dr. Shams Tabrez received his Ph.D degree in Biochemistry from Aligarh Muslim University, India in the year 2010. Currently, he is working as Associate Professor at King Fahd Medical Research Center (KFMRC), King Abdulaziz University (KAU), Jeddah, Saudi Arabia. He has vast experience in the field of clinical pharmacology. He is also having a strong research interest in the field of natural compounds based therapy which has fetched him a good number of publications. He had published 115 articles in the journals of international repute till date and some more are in pipeline. He has been also credited to publish a book and 2 chapters with reputed international publishing agency based in Germany (Total citations: 2115; h-index: 26; i10-index: 65). Dr. Tabrez has successfully accomplished four research grant funded by KACST and KAU as a principal investigator. Currently, he is running 5 different projects as principal and co-investigator. He has generated more than 2.35 million Saudi Riyals in research funds either as PI or as CO-I.

Prof. RX Tan is a chair professor and vice president at Nanjing University of Chinese Medicine, with his concurrent chair-professorship at Nanjing University. He has been well established in the field of drug discovery and medicinal chemistry. He has published over 330 articles with over 10,000 citations in respected journals such as Nat Commun, PNAS, J Am Chem Soc, and Angew Chem. As a Fellow of the Royal Society of Chemistry (UK), he is at the editorial (advisory) boards of Natural Product Reports, Current Medicinal Chemistry, Frontiers in Plant Sciences, and others.

Dr. CG Tocchetti is Associate Professor of Medicine, Naples, Italy. He is a basic and clinical investigator and coordinates the HF outpatient unit. His studies in Baltimore have helped dissecting the cardiac contractile effects of HNO and the development of a novel HNO donor for treating human HF currently used in clinical trials. Hence, the main goal of his lab is to explore pathophysiologic mechanisms and therapeutic targets in cardiac dysfunction, particularly in post-ischemic HF, genetic and inflammatory cardiomyopathies, Pulmonary Hypertension and RV dysfunction, and HF due to antineoplastic therapies, including novel anticancer immunotherapies and biologic drugs for inflammatory diseases.

Dr. Neşe Tunçel received her BS in Pharmacy in 1970 and her PhD in Medical Physiology in 1982 from Ankara University, Turkey. She has been served as a Professor in the Department of Physiology and Neurophysiology, Faculty of Medicine, Eskişehir Osmangazi University, and she was retired in April 2016. She has 95 scientific publications. She also serves as a member of the Editorial boards of several academic journals including Current Pharmaceutical Design, Medicinal Chemistry, Recent Patents on Anti-Cancer Drug Discovery, The Open Cancer Journal, Biomedical Review and Adipobiology, Current Clinical pharmacology. She has also served in the Editorial Advisory Board of Peptides in the period 1998-2010 and, Immunology, Endocrine and Metabolic Agents for three years.

Prof. Tuttolomondo, obtained two post graduate degree ( Internal Medicine and Neurology) and a doctorate (Ph.D.) in Genetic and Pathophysiology of Cardiovascular Damage in Metabolic Diseases from the University of Palermo ( Italy) Currently Prof. Tuttolomondo is Associate Professor in Internal Medicine in University of Palermo ( Italy). He has published more than 130 scientific publications on international, ISI and medium-high impact factor journals and inherent in the pathophysiology and epidemiology of ischemic stroke, heart failure, diabetic foot and Anderson-Fabry Disease .

Jingwei Xie received his B.S. (1999) and M.S. (2002) from Nanjing University of Technology, China, and his Ph.D. from the National University of Singapore (2007). He worked as a postdoctoral fellow in the Xia group at Washington University in St. Louis (2007-2011) and then as a Senior Scientist at Marshall University (2011-2013). He is currently an Assistant Professor in the Department of Surgery-Transplant and Holland Regenerative Medicine Program at the University of Nebraska Medical Center. His research interests include biomaterials, drug delivery, nanomedicine, tissue engineering, and regenerative medicine.

Bing Yan got his Ph.D. from Chemistry Department of Columbia University in 1990. He then carried out postdoctoral research at Physiology Department of University of Cambridge, U.K. and Department of Microbiology and Molecular Genetics at University of Texas Medical School in Houston from 1990 to 1993. From 1993 to 2005, he carried out drug discovery research at Novartis, Discovery Partners International, and Bristol-Myers Squibb. He was a Full Professor and Director of High-Throughput Analytical Chemistry Center at Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital in Memphis, Tennessee from 2007 to 2012 and Cheung Kong Scholar Professor at Shandong University, Jinan, China since 2005. He served as Associate Editor for “Journal of Combinatorial Chemistry (name now changed to ACS Combinatorial Sciences)” published by American Chemical Society from 2009 to 2011. He is now serving as Associate Editor for both “Ecotoxicology and Environmental Safety” and Elsevier’s new journal “NanoImpact”. He is also editor of book series “Critical Reviews in Combinatorial Chemistry” published by Francis & Taylor Group. He has published 11 books and more than 210 peer-reviewed papers. He is interested in drug discovery, nanomedicine, and modulation of biological activities of nanoparticles using systematic approaches.

Dr. Wuli Yang is currently a Professor in the Department of Macromolecular Science at Fudan University. He received his BS degree in 1995, MS degree in 1998 and PhD degree in 2001 from Fudan University. His current research interest is focused on functional inorganic nanoparticles, functional polymeric composite microspheres and biomedical nanoparticles for diagnostic and drug delivery. Prof. Yang has co-authored more than 170 peer-reviewed papers, and is the recipient of 16 Chinese patents. His publications have been cited over 6600 times with current H-index of 48.

Xiaojun Yao received his Ph.D. degree in chemoinformatics and theoretical chemistry from University Paris 7-Denis Diderot, Paris, France, in 2004. He works as a Professor of chemoinformatics and analytical chemistry in College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China. His current research interests include computer-aided molecular design, bioinformatics, and computational biology.

Dr. Hong Zhang received his Ph.D. degree in formulaology from Chengdu University of Traditional Chinese Medicine in May 2005. He joined the Second Military Medical University as a lecturer in June 2005 and became an associate professor in 2009. He moved to Shanghai University of Traditional Chinese Medicine as an associate professor in August, 2018. Currently his research interests are focused on the anti-cancer activity, target and compatibility mechanism for Chinese medicines and natural products.

Dr. Xiang has obtained Ph.D. in Psychopharmacology from the Institute of Mental Health, Peking University School of Medicine, Beijing CHINA. He is presently serving as an Associate Professor at the University of Texas Health Science Center at Houston, Texas, USA. He has been awarded The Beijing Science and Technology Award in 2008, Senior Scientist Award in 2006, Travel Award, the American College of Neuropsychopharmacology in 2005 and many others. His skills and expertise are in Molecular Biology, Psychopathology, Clinical Psychiatry, Psychopharmacology and Neuropsychology. He has contributed more than 245 publications, having citations around 5,159

Dr. Qi (Tony) Zhou is an Assistant Professor in the Department of Industrial and Physical Pharmacy at Purdue University. He obtained his PhD from Monash University of Australia and received postdoctoral training at the University of Sydney. Dr. Zhou’s research focuses on pharmaceutical solid dosage forms, pharmaceutical manufacturing and pulmonary drug delivery systems. He has secured numerous research funding from Governments, organizations and pharmaceutical industry, including NIH R01 and Bill & Melinda Gates Foundation grants. Dr. Zhou’s contributions to the field of pharmaceutical sciences have been recognized by many awards including 2013 Australian Early Career Fellowship, 2014 Australian Endeavour Fellowship, 2015.

Shaobing Zhou received his B.S. degree in polymer chemistry from Sichuan University in 1996 and Ph.D. degree in Chinese Academy of Sciences in 2003. He was promoted in 2005 to Full Professor at Southwest Jiaotong University. His research interests include drug controlled release system and tissue engineering scaffold. He is the author or coauthor of more than 120 refereed articles, 1 book chapter and 15 Chinese patents/patent applications. He has been cited over 3500 times and has an h-index of 39 Currently he is one of associate editors of the journal: American Journal of Materials Science.

Seyed Hamid Aghaee-Bakhtiari, is an assistant professor of Biotechnology Research Center and Department of Medical Biotechnology at the Mashhad University of Medical Sciences, Iran. He received his PhD from the Pasteur Institute of Iran to evaluate effective microRNAs of androgen receptor in the suppression of prostate cancer at the Pasteur Institute of Iran. He developed miRandb database, a meta-database of online services for microRNA research, which was published in briefings in bioinformatics. He compiled two book chapters for non-coding RNA databases for springer. He is developing several databases about miRNA and disease relationships, miRNA target prediction and miRNA target validation.

Dr. Gupta is Principal Scientist at Formulation & Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Jammu. Dr. Gupta graduated in Pharmacy and obtained his Ph.D. in Pharmaceutical Sciences from the Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.) India. He did postdoctoral research work in Drug Delivery & Biomaterial Research Group, School of Pharmacy, Queen's University of Belfast, UK with the prestigious fellowship from Bill & Melinda Gates foundation, USA & Wellcome trust, UK. He is recipient of most coveted industrial awards including Young Scholar Award by Ranbaxy Science Foundation (2007) and Formulation & Drug Delivery Leadership Award (2019). He has to his credit many publications in international journal of repute. Dr. Gupta is a member of many professional bodies and reviewer for various prestigious journals.

Dr. Majid Khazaei is currently working as a Professor of Physiology at the Department of Physiology, Mashhad University of Medical Sciences, Mashhad, Iran. He obtained his PhD. in physiology from the Department of physiology, Isfahan University of Medical Sciences. He received his Doctor of Medicine degree in 1998 from Mashhad University of Medical Sciences, Mashhad, Iran. Dr. Khazaei has numerous honors, awards and publications to his credit.

Na’il Saleh received his PhD in Photochemistry from University of Missouri, USA in 2002. He worked as an Assistant Professor of physical chemistry at Yarmouk university, Jordan from 2002-2009. He was also appointed from 2006 to 2008 as a Research Scientist at Jacob university Bremen in Germany. In 2013, he was promoted to Associate Professor by United Arab Emirates University (joined 2009). With more than 48 publications, his research has been focusing on designing and creating new smart constitutional materials with inherent reversibility and responsiveness to chemical and thermal stimuli that have potential applications in biology, energy and environment using a non-classical approach.

Dr. Muthu Thiruvengadam is Associate Professor, Department of Applied Bioscience, Konkuk University, Seoul, South Korea. He has obtained his PhD in Biotechnology, Bharathidasan University, India. During his training as a Postdoctoral Scientist from the Jawaharlal Nehru University, India and National Chung Hsing University, Taiwan, he gained a lot of experience to be molecular biology techniques and bioactive compounds identification using metabolomics tools against pharmacological activities. His main interest is in bioactive compounds, biomedical applications and nanotechnology. He has over 100 peer-reviewed publications and is the recipient of several grants and awards.

Chunlin Zhuang received his bachelor’s degree from Nanjing Medical University, China (2009) and a Ph.D. in medicinal chemistry from Second Military Medical University (2014). In 2012-2013, he worked at the University of Minnesota as an exchange Ph.D. candidate. He has worked as a faculty member at the School of Pharmacy, Second Military Medical University from 2014 and in Prof. Fener Chen’s group at Fudan University from 2019 as a professor. He has held a joint professorship at Ningxia Medical University. His research interests include computer-aided drug design, medicinal chemistry and chemical biology.

The experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. Skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. He has focused on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many originals and reviews in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, he certificates for placing in the top 1% of reviewers in Cross-Field on Publons global reviewer database.

Dr. Gjumrakch Aliev received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1989 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. Dr. Aliev’s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. He is currently the Editor in Chiefs for “Central Nervous System Agents in Medicinal Chemistry”, “Applied Cell Biology”, “World Journal of Neuroscience”, “Open Journal of Psychiatry”, “Journal of Aging Science”, “Cardiovascular & Hematological Agents in Medicinal Chemistry”, “Immunology, Endocrine and Metabolic Agent in Medicinal Chemistry” as well as which by itself shows the voluminous and outstanding work he has accomplished in the area of cellular and molecular biology as well as aged associated clinical sciences.

Prof. Sanjula Baboota is presently working at the Department of Pharmaceutics, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard. She has a total experience of about 23 years in teaching and research. She has a list of over 200 publications in high impact factor refereed journals. She has guided several students both at the at the postgraduate and doctorate level. She has more than 7300 citations and has an h-index of 43 and i10 index of 120 (Source: Google Scholar).

Prof. Dr. Marcio F. Chedid obtained his MD degree by the Medical School of the Federal University of Rio Grande do Sul (UFRGS) in Porto Alegre, Brazil in 2004. Prof. Chedid concluded a five-year General Surgery and Surgical Oncology Residency at Hospital de Clínicas de Porto Alegre (HCPA-UFRGS) in Porto Alegre, Brazil in 2010. He worked as a Clinical Fellow at the Division of Abdominal Transplantation Surgery of Mayo Clinic in Rochester, Minnesota USA, from 2011 to December 2013. Since May 2014, Prof. CHEDID is an Attending Liver and Pancreas Transplant Surgeon at HCPA-UFRGS. Prof. Chedid obtained a PhD degree in Surgical Sciences at UFRGS in February 2017 and has worked as Postgraduate Professor of Surgery and Master´s Degree Thesis Advisor at the Medical School of UFRGS since September 2017. He has authored/co-authored 47 scientific medical articles, including the one first reporting successful performance of human pancreas transplantation utilizing IGL-1 preservation solution (https://www.ncbi.nlm.nih.gov/pubmed/27163542). Prof. Chedid is one of the associate editors of the World Journal of Gastrointestinal Surgery and also is a member of the editorial board of Annals of Translational Medicine and Lipids in Health and Disease. Prof. Chedid is a reviewer for 31 PubMed Indexed scientific journals. 

Dr. Jiwei Hu is currently a Chair Professor at Guizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment as well as at Cultivation Base of Guizhou National Key Laboratory of Mountainous Karst Eco-environment, Guizhou Normal University. He obtained B.S. in chemical engineering from Zhejiang Institute of Technology in 1984, M.S. in organic chemistry from University of Jyväskylä in 1994, Licentiate in environmental chemistry from Stockholm University in 1996, and Ph.D. in applied chemistry from University of Jyväskylä in 1999. He carried out his research at College of Chemistry and Molecular Engineering, Peking University, as a Post-Doctoral Fellow from 2002 to 2005. He received in 2018 the International Association of Advanced Materials (IAAM) medal in Sweden and the Science Technology Cooperation Award of Guizhou Province. He has so far authored and co-authored approximately 180 conference and journal papers and his work has led to 7 patents.

Prof. Dr. Sher Bahadar Khan did his Ph.D from HEJ, Karachi University, Pakistan. After completion of Ph.D, He started his post-doctoral career in Nanochemistry and Nanotechnology and continued to work as a post-doctoral research fellow till February 2010 at Yonsei University, South Korea. In March 2010, He joined Center for Advanced Materials and Nano-engineering, Department of Chemistry, Najran University as an Assistant Professor and continued his work till 31 st August 2011. He joined the Chemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia as an Assistant Professor in September 2011. Currently he is full Professor in the Chemistry Department, King Abdulaziz University and is doing research in Nanochemistry and Nanotechnology which comprises catalysis, hydrogen production, drug delivery, solar cell, development of active photo-catalyst and fabrication of perceptive bio-sensor and chemi-sensor using metal oxide nanomaterials and their green environmental nanohybrids. He is the author of 300 research articles, twelve books, and six patents with more than 850 impact factor, 5650 citations and 41 h-index.

Dr Bikash Medhi is a Professor & Additional Medical Superintendent (AMS) in PGIMER, Department of Pharmacology. His area of expertise is Experimental Pharmacology, Clinical Research, Regulatory Pharmacology, and Development of nano-formulations, Pharmacogenetics, Pharmacogenomics and Stem cells etc. He has more than 20 years of teaching and research experience and has owned more than 60 prestigious national and international awards He is in core panel of expert for Task Force in IND application & Regulatory Affair, lead GLP Inspector, lead GCP inspector, Principle Assessor for NABH, He is in several committees in DCGI office, ICMR, DBT, DST, CSIR, NBE, MCI etc. He has authored five books and 80 chapters and published more than 350 articles in national and international journals.

Dr. Feng Xu (MD, PhD) obtained his PhD from Zhejiang University. Following postdoctoral work at Shantou University, he became an associate Professor at the First Affiliated Hospital of Shantou University Medical College in China. He devotes himself in the research of pathogenesis of chronic airway diseases and lung cancer for many years, and has been invited to academic discussion and experience sharing at academic conferences for many times. He has published more than twenty papers recruited by SCI database.

Weiwei Xue received his B.S. (2009) and Ph.D. (2014) degree in Department of Chemistry at Lanzhou University. He worked as a visiting scholar of the Department of Biochemistry at University of Washington School of Medicine (2018-2019). He is now an associate professor of the School of Pharmaceutical Sciences at Chongqing University. His research interests focus on employing principles of physics and chemistry with modern computational techniques to understand the molecular mechanism underlying chemical and biological processes (protein−ligand/protein interactions and protein folding), and to design novel therapeutic candidates. Dr. Xue has published more than 50 peer-reviewed research papers with over 1000 citations and h-index of 23.

Ali Yadollahpour received his MSc and PhD in Medical Physics from Tarbiat Modares University, Tehran, Iran in 2013. He has served as the head of Bioelectromagnetic Clinic in Imam Hospital, Ahvaz, Iran. He is the faculty member of Medical Physics department, School of Medicine in Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. His main research interests are experimental and quantitative neuroscience, cognitive neuroscience, brain stimulation, neuromodulation, using physical modalities and nanoscale agents in medical theranostics. He is currently working on neuromodulation/neurofeedback for treatment of neuropsychiatric disorders.

Dr Donghong Zhang is currently serving as a Research Assistant Professor at the Center for Molecular and Translational Medicine of Georgia State University, USA. He completed his M.S. from Shantou University Medical College, China. He further obtained a PhD from Peking Union Medical College Hospital, China in 2012. His research interests include Role of epigenetics, genetics and metabolomics in heart development, heart regeneration, atherosclerosis and lung cancer in vivo and in vitro. He has contributed his valuable publications in different scientific journals.